Funds holding Sionna Therapeutics Inc
ISIN US8294011080 · United States
- Fund holders
- 127
- Of which ETFs
- 30 97 other funds
- Value held
- 234.6M $
- Share of capital
- 13.2 % of 45.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 709 | 28.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 694 | 25.4K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 661 | 24.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 584 | 23.4K $ | 0.32 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 550 | 22K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 510 | 19.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 423 | 15.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 400 | 16K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 367 | 14.7K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 365 | 14.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 362 | 14.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 245 | 9.5K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 228 | 9.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 183 | 7.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 168 | 6.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 149 | 5.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 78 | 3.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 63 | 2.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 54 | 2.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 41 | 1.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 37 | 1.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 30 | 1.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 24 | 962.2 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 22 | 882 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 16 | 584.6 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 5 | 182.7 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 4 | 160.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 1.63 % | as of Feb 27, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.63 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.05 % | as of Feb 28, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 1.02 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.67 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 0.50 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 0.49 % | as of Mar 31, 2026 ↗ |
| JPMorgan Healthcare Leaders ETF J.P. Morgan Exchange-Traded Fund Trust | 0.42 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.36 % | as of Feb 28, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 0.32 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 127 | +14 | 5,972,262 | +1.9 % |
| 2026Q1 | 113 | +25 | 5,860,543 | +23.1 % |
| 2025Q4 | 88 | +18 | 4,761,799 | +23.7 % |
| 2025Q3 | 70 | +47 | 3,849,220 | +22.9 % |
| 2025Q2 | 23 | 3,132,928 |
Institutional managers
116 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9,905,045 | 397.1M $ | as of Mar 31, 2026 |
| TPG GP A, LLC | 6,494,962 | 260.4M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 3,530,702 | 141.5M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 3,195,181 | 128.1M $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 2,995,602 | 120.1M $ | as of Mar 31, 2026 |
| ENAVATE SCIENCES GP, LLC | 2,478,030 | 99.3M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,465,014 | 53.7M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 1,451,220 | 58.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,295,867 | 52M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,166,931 | 46.8M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 970,590 | 38.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 756,376 | 30.3K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 756,227 | 30.3M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 658,439 | 26.4M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 645,530 | 25.9M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 564,175 | 22.6M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 400,000 | 16M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 389,872 | 15.6M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 300,000 | 12M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 294,340 | 11.8M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 293,500 | 11.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 263,174 | 10.6M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 255,636 | 10.2M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 236,813 | 9.5M $ | as of Mar 31, 2026 |
| Kalehua Capital Management LLC | 197,072 | 7.9M $ | as of Mar 31, 2026 |
Declared shareholders of Sionna Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP and 9 others | 7.10 % | 3,195,181 | as of Mar 31, 2026 · SCHEDULE 13G |
| ORBIMED ADVISORS LLC and 1 other | 6.60 % | 2,967,722 | as of Apr 15, 2026 · SCHEDULE 13D |
| Qatar Investment Authority and 1 other | 4.50 % | 2,020,258 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Sionna Therapeutics Inc". https://titelia.com/en/stocks/sionna-therapeutics-inc-US8294011080